Genetic testing for cardiovascular disease susceptibility: a useful clinical management tool or possible misinformation?

@article{Humphries2004GeneticTF,
  title={Genetic testing for cardiovascular disease susceptibility: a useful clinical management tool or possible misinformation?},
  author={Steve E Humphries and Paul M. Ridker and Philippa J. Talmud},
  journal={Arteriosclerosis, thrombosis, and vascular biology},
  year={2004},
  volume={24 4},
  pages={628-36}
}
Genetic susceptibility tests are already advertised on the Internet to identify individuals at above average risk for cardiovascular disease (CVD), such as deep vein thrombosis, hyperlipidemia, or atherosclerosis, whereas other tests claim to predict response to a particular drug treatment. Some kits are available to the public directly, bypassing a doctor. Their value, however, must be considered carefully, because although a genotype may be strongly and consistently associated with an… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 30 extracted citations

Introducing genetic testing for cardiovascular disease in primary care: a qualitative study.

The British journal of general practice : the journal of the Royal College of General Practitioners • 2014

Cardiovascular Genomics: A Biomarker Identification Pipeline

IEEE Transactions on Information Technology in Biomedicine • 2012
View 2 Excerpts

References

Publications referenced by this paper.
Showing 1-10 of 84 references

Endothelial Nitric Oxide Synthase Genotype and Ischaemic Heart Disease: Meta-Analysis of 30 Studies, Involving 23721 Subjects

JP Casas, SE Humphries, AD. Hingorani
Circulation 2003;in press • 2004

Similar Papers

Loading similar papers…